Shionogi to Present In Vitro and Real-World Data at IDWeek 2021 Demonstrating Activity of FETCROJA® (cefiderocol) Against Gram-Negative Pathogens

Shionogi & Co., Ltd. (hereafter “Shionogi”) today announces that 11 abstracts on FETCROJA® (cefiderocol) will be shared at IDWeek. The meeting will take place virtually from September 29 – October 3, …
( read original story …)

---